Millendo is working to ease the burden of patients with severe endocrine diseases
Millendo is leveraging novel biological insights to advance a portfolio of endocrine therapeutics
Millendo is restoring hormonal balance to patients with endocrine diseases
August 20, 2019Millendo Therapeutics Appoints Tamara Joseph as General Counsel and Ryan Zeidan as Chief Development Officer
August 12, 2019Millendo Therapeutics Reports Second Quarter 2019 Operating and Financial Results
